Cerus (CERS) Total Debt Growth (1y) (2011 - 2026)
Cerus (CERS) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | -5.76% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 19.06% |
| 10 | Cerus | 605.72 Mn | 525.30 Mn | 27.89 Mn | -0.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.17% |
| Dec 31, 2025 | -0.32% |
| Sep 30, 2025 | 1.84% |
| Jun 30, 2025 | 1.52% |
| Mar 31, 2025 | 0.03% |
| Dec 31, 2024 | 5.47% |
| Sep 30, 2024 | 6.11% |
| Jun 30, 2024 | 17.15% |
| Mar 31, 2024 | 16.64% |
| Dec 31, 2023 | 14.32% |
| Sep 30, 2023 | 12.66% |
| Jun 30, 2023 | 2.34% |
| Mar 31, 2023 | 4.37% |
| Dec 31, 2022 | 0.55% |
| Sep 30, 2022 | 7.85% |
| Jun 30, 2022 | 8.96% |
| Mar 31, 2022 | 8.10% |
| Dec 31, 2021 | 44.31% |
| Sep 30, 2021 | 45.22% |
| Mar 31, 2021 | 45.82% |